The advertisement promotes Entyvio as a superior treatment option compared to Humira for patients with moderately to severely active ulcerative colitis, highlighting its efficacy in clinical remission and providing important safety information.
Creative Information
| CID: | c75a30d5-c871-4172-949b-b114d47c484f |
| CRID: | 82_6854-851818 |
| Domain: | entyviohcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $16.26 |
| Timestamp: | 11/18/2025, 9:30:40 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/19/2025, 12:11:21 AM | 6.13s | |
| adomain_analysis | success | 11/19/2025, 2:52:10 AM | 2.83s | |
| adomain_capture | success | 11/19/2025, 2:51:44 AM | 0.08s | |
| ad_render | success | 11/19/2025, 12:11:15 AM | 25.17s | |
| brand_mapping | success | 11/18/2025, 9:30:41 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Entyvio
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1599.76 KB | ||||||||||||||||||||||
| Render Time: | 9.45 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1599.88 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
